GLP-1s and Breast Cancer: What You Need to Know

In this episode, Chris and Jenni sit down with Paige Woodward, NP, a Yale-trained nurse practitioner with over 20 years of oncology experience (Dana-Farber, Cedars-Sinai), to break down everything breast cancer patients and survivors need to know about GLP-1 medications — the class of drugs behind Ozempic, Wegovy, and Mounjaro. Topics covered: How GLP-1s work and why weight loss matters for estrogen-positive breast cancer San Antonio Breast Cancer Conference data: women on GLP-1s during chemo had fewer side effects (less neuropathy, nausea, neutropenia, and fatigue) Emerging evidence linking GLP-1s to reduced tumor recurrence and lower colorectal cancer risk Safety, proper dosing, and the importance of nutrition and exercise GLP-1s and reduced alcohol cravings — a bonus for cancer risk reduction Guest: Paige Woodward, NP — @FunctionalCancerCare on Instagram | Vibrant Integrative Health | Licensed in CA, MA & NH Learn more about your ad choices. Visit podcastchoices.com/adchoices